Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study on application methods of topical Timolol after ablative fractional CO2 laser
TCTR20250118009Phase 2Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of timolol in cutaneous wound (2 arms), sponsored by Ramathibodi Hospital. Started Jan 2022; status: completed.
02
Drugs
timolol
03
Conditions
cutaneous wound
Beyond the preview
Go deeper on TCTR20250118009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250118009.